Organisation paid for research Program year 2021 Source: CMS Open Payments

Allcutis Research, Inc.

Neither a doctor nor a teaching hospital

Research payments

$233,691

11 payments

Through program year 2021, Allcutis Research, Inc. is reported as receiving $233,691 in research payments, across 11 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$124,492	8
2020	Research	$109,200	3

Breakdown

Who paid Research payments · program years 2020–2021

Ucb SA $109,200 3 payments
Amgen Inc. $74,313 1 payment
Eisai Inc. $50,179 7 payments

Studies the money was for Research payments · program years 2020–2021

ABP 654 P3 PsO Study $74,313 1 payment
A Phase 3, Randomized, Double-Blind, Placebocontrolled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa $62,247 1 payment
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease $50,179 7 payments
A Phase 3, Randomized, Double-Blind, Placebocontrolled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa $46,953 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.